Published in Curr Cardiovasc Risk Rep on October 01, 2011
Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction | NCT01516346
Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol (2012) 1.59
Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation (2013) 1.48
The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep (2013) 1.11
Aging of the United States population: impact on heart failure. Curr Heart Fail Rep (2012) 1.00
Exercise intolerance in heart failure with preserved ejection fraction: shifting focus from the heart to peripheral skeletal muscle. J Am Coll Cardiol (2012) 0.95
Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med (2013) 0.93
A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis? J Cell Mol Med (2014) 0.82
Heart failure in elderly: progress in clinical evaluation and therapeutic approach. J Geriatr Cardiol (2013) 0.80
Effect of Age, Estrogen Status, and Late-Life GPER Activation on Cardiac Structure and Function in the Fischer344×Brown Norway Female Rat. J Gerontol A Biol Sci Med Sci (2016) 0.77
Time-Dependent Regional Myocardial Strains in Patients with Heart Failure with a Preserved Ejection Fraction. Biomed Res Int (2016) 0.77
Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis. BMC Cardiovasc Disord (2016) 0.75
Treating Heart Failure with Preserved Ejection Fraction: A Challenge for Clinicians. Hosp Pharm (2015) 0.75
Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor. P T (2015) 0.75
Ergospirometry and Echocardiography in Early Stage of Heart Failure with Preserved Ejection Fraction and in Healthy Individuals. Arq Bras Cardiol (2015) 0.75
Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction. Heart Vessels (2017) 0.75
Heart failure with preserved ejection fraction: a nephrologist-directed primer. Heart Fail Rev (2017) 0.75
Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction. J Am Heart Assoc (2017) 0.75
Estimation of Diastolic Filling Pressure with Cardiac CT in Comparison with Echocardiography Using Tissue Doppler Imaging: Determination of Optimal CT Reconstruction Parameters. Korean J Radiol (2017) 0.75
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes. Diabetes Care (2017) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med (1994) 11.54
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med (2008) 9.62
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med (2005) 5.52
Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med (2008) 4.98
The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med (2001) 4.94
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation (2003) 4.43
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA (2002) 4.06
Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? J Am Coll Cardiol (2004) 3.89
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys J (1995) 3.71
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation (2003) 3.62
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation (2007) 3.12
Myocardial structure and function differ in systolic and diastolic heart failure. Circulation (2006) 3.11
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93
Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol (2006) 2.61
Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59
Death in heart failure: a community perspective. Circ Heart Fail (2008) 2.46
Cardiomyocyte stiffness in diastolic heart failure. Circulation (2005) 2.43
Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail (2010) 2.35
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol (2004) 2.17
Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail (2005) 2.11
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation (2001) 2.05
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res (2009) 1.99
Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail (2010) 1.93
Cardiac titin: a multifunctional giant. Circulation (2010) 1.84
Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension (2010) 1.64
Consistency with the DASH diet and incidence of heart failure. Arch Intern Med (2009) 1.50
Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing. Circulation (2008) 1.45
Heart failure with a normal ejection fraction. Heart (2005) 1.41
Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA (2008) 1.40
Age disparities in heart failure research. JAMA (2010) 1.23
Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med (2008) 1.12
Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol (2004) 1.09
Interpretation of echocardiographic measurements: a call for standardization. Am Heart J (2000) 1.03
Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction. Curr Heart Fail Rep (2009) 1.03
Molecular determinants of heart failure with normal left ventricular ejection fraction. Pharmacol Rep (2009) 1.02
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol (2009) 0.97
Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med (2008) 0.96
Myocellular and interstitial edema and circulating volume expansion as a cause of morbidity and mortality in heart failure. J Card Fail (2007) 0.96
Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens (2004) 0.96
Invasive hemodynamic assessment in heart failure. Heart Fail Clin (2009) 0.95
Structural and physiological age-associated changes in aging lungs. Semin Respir Crit Care Med (2010) 0.93
Aging of the autonomic nervous system and possible improvements in autonomic activity using somatic afferent stimulation. Geriatr Gerontol Int (2010) 0.93
Recommendation of low-salt diet and short-term outcomes in heart failure with preserved systolic function. Am J Med (2009) 0.88
Constitutive properties of adult mammalian cardiac muscle cells. Circulation (1998) 0.88
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk. Curr Vasc Pharmacol (2007) 0.87
Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? Prog Cardiovasc Dis (2005) 0.86
Myocardial ischemia in patients with diastolic dysfunction and heart failure. Curr Cardiol Rep (2010) 0.86
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Eur Heart J (2008) 0.84
Left ventricular function in hospitalized geriatric patients. J Am Geriatr Soc (1982) 0.84
Hypertension and angiogenesis in the aging kidney: a review. Arch Gerontol Geriatr (2010) 0.84
Heart failure: a rose by any other name? Congest Heart Fail (2006) 0.81
Reproducibility of Doppler echocardiographic assessment of left ventricular diastolic function in multicenter setting. J Am Soc Echocardiogr (2005) 0.77
Serial BNP assay in monitoring exercise tolerance in patients with diastolic dysfunction. Int J Cardiol (2011) 0.77
Partial hospitalisation gives patients with mental health problems. Nurs Times (1998) 0.76
Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J (2008) 2.85
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging (2013) 2.20
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv (2012) 2.08
Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? J Am Coll Cardiol (2015) 2.02
Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol (2011) 1.69
Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application. Am J Physiol Heart Circ Physiol (2006) 1.50
Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation (2003) 1.32
Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography. J Am Coll Cardiol (2002) 1.16
THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin (2012) 1.16
Self-reported lack of energy (anergia) among elders in a multiethnic community. J Gerontol A Biol Sci Med Sci (2008) 1.14
Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2005) 1.12
Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol (2004) 1.09
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail (2010) 1.07
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J (2012) 1.07
The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid (2014) 1.04
Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction. Curr Heart Fail Rep (2009) 1.03
Transthyretin cardiac amyloidoses in older North Americans. J Am Geriatr Soc (2012) 1.03
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02
A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest (2013) 1.00
Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clin Cardiol (2012) 0.99
Diflunisal for ATTR cardiac amyloidosis. Congest Heart Fail (2012) 0.99
Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol (2013) 0.98
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol (2009) 0.97
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology. Curr Med Res Opin (2012) 0.97
Maximum daily 6 minutes of activity: an index of functional capacity derived from actigraphy and its application to older adults with heart failure. J Am Geriatr Soc (2010) 0.96
The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail (2010) 0.96
Myocellular and interstitial edema and circulating volume expansion as a cause of morbidity and mortality in heart failure. J Card Fail (2007) 0.96
Exercise intolerance in heart failure with preserved ejection fraction: shifting focus from the heart to peripheral skeletal muscle. J Am Coll Cardiol (2012) 0.95
Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions. Am J Cardiol (2008) 0.92
Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis. J Immunol (2011) 0.92
The cardio-renal-anemia syndrome in elderly subjects with heart failure and a normal ejection fraction: a comparison with heart failure and low ejection fraction. Congest Heart Fail (2006) 0.91
The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells. J Immunol (2007) 0.91
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev (2015) 0.89
Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS). JMIR Mhealth Uhealth (2016) 0.87
Heart failure with a normal ejection fraction (HFNEF): embracing complexity. J Card Fail (2009) 0.86
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. Congest Heart Fail (2010) 0.86
Quantification of transthyretin kinetic stability in human plasma using subunit exchange. Biochemistry (2014) 0.85
High burden of palliative needs among older intensive care unit survivors transferred to post-acute care facilities. a single-center study. Ann Am Thorac Soc (2013) 0.85
Relation of patients living without a partner or spouse to being physically active after acute coronary syndromes (from the PULSE accelerometry substudy). Am J Cardiol (2013) 0.84
Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical center. Aging health (2013) 0.84
Cardiac amyloidosis: the great pretender. Heart Fail Rev (2015) 0.84
A clinical algorithm to differentiate heart failure with a normal ejection fraction by pathophysiologic mechanism. Am J Geriatr Cardiol (2006) 0.84
The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. J Card Fail (2011) 0.83
Facilitating clinical trials of anemia in older adults: a point-of-care system to measure hemoglobin in the home and its agreement with a hospital core laboratory. J Am Geriatr Soc (2009) 0.82
Ventriculovascular coupling in systolic and diastolic heart failure. Curr Heart Fail Rep (2005) 0.82
Noncompressibility of myocardium during systole with freehand three-dimensional echocardiography. J Am Soc Echocardiogr (2002) 0.82
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). Amyloid (2015) 0.81
Changing nature of cardiac interventions in older adults. Aging health (2011) 0.81
Heart failure with a preserved ejection fraction: what is in a name? J Am Coll Cardiol (2011) 0.80
Overestimation of left ventricular mass and misclassification of ventricular geometry in heart failure patients by two-dimensional echocardiography in comparison with three-dimensional echocardiography. Echocardiography (2009) 0.80
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation (2016) 0.80
Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review. Amyloid (2011) 0.80
Prevalence and characteristics of anergia (lack of energy) in patients with acute coronary syndrome. Am J Cardiol (2012) 0.80
Aortic regurgitation during systolic-phase accompanied by mitral regurgitation in patients with continuous-flow left ventricular assist device. Eur Heart J Cardiovasc Imaging (2013) 0.79
A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction. Cardiovasc Ther (2011) 0.79
Assessment of age-related changes in left ventricular structure and function by freehand three-dimensional echocardiography. Am J Geriatr Cardiol (2005) 0.78
Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia. Congest Heart Fail (2011) 0.78
Ventriculovascular coupling in systolic and diastolic heart failure. Curr Cardiol Rep (2006) 0.77
Health-related restrictions of choices and choosing: implications for quality of life and clinical interventions. Patient Relat Outcome Meas (2010) 0.77
Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor. J Clin Neuromuscul Dis (2016) 0.77
Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol (2014) 0.77
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Am Coll Cardiol (2016) 0.77
Cardiac transplantation in patients with hypertrophic cardiomyopathy. Am J Cardiol (2012) 0.77
Perioperative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. Congest Heart Fail (2010) 0.77
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy. J Clin Neuromuscul Dis (2014) 0.77
Inpatient care for nursing home patients: an opportunity to improve transitional care. J Am Med Dir Assoc (2006) 0.76
Diastolic heart failure. N Engl J Med (2004) 0.76
Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9. Congest Heart Fail (2011) 0.76
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction? JACC Heart Fail (2016) 0.75
Heart failure with a normal ejection fraction: treatments for a complex syndrome? Curr Treat Options Cardiovasc Med (2012) 0.75
Obesity and the risk of heart failure. N Engl J Med (2002) 0.75
Age: a nonmodifiable risk factor? J Am Coll Cardiol (2003) 0.75
Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial. J Card Fail (2013) 0.75
Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial. Congest Heart Fail (2013) 0.75
Geriatric assessment of older adults with heart failure: an essential tool in planning of care. Am J Med (2013) 0.75
Transthyretin Val30Met mutation in an African American with cardiac amyloidosis. Congest Heart Fail (2010) 0.75
Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions. J Am Coll Cardiol (2012) 0.75
Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness. Crit Care Med (2017) 0.75
Quality of life impacts on 16-year survival of an older ethnically diverse cohort. Int J Geriatr Psychiatry (2013) 0.75
Emerging role of serelaxin in the therapeutic armamentarium for heart failure. Curr Atheroscler Rep (2014) 0.75
Life and works of Sidney Katz, MD: a life marked by fundamental discovery. J Am Med Dir Assoc (2012) 0.75
Absence of heart failure in severe cardiac and autonomic amyloidosis: the essential role of sympathetic activation and venous tone in the development of the congestive heart failure syndrome. Congest Heart Fail (2009) 0.75
Transthyretin cardiac amyloidosis diagnosed by analyzing a prostatic tissue sample: a case report. J Am Geriatr Soc (2011) 0.75
Timing does matter: evaluating the effect of comprehensive geriatric assessments on knowledge and attitudes in Year 1 of residency. J Am Geriatr Soc (2014) 0.75
Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol (2017) 0.75
Physiologic determinants of mitral inflow pattern using a computer simulation: insights into Doppler echocardiography in diverse phenotypes. Echocardiography (2009) 0.75